COVID-19: Antibody therapy likely to lower hospitalisations, emergency visits
Los Angeles: COVID-19 patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalisation or emergency medical care than those who did not receive the therapy, according to a new study. The ongoing Phase II clinical trial, whose interim...











































